719 XTX301, a protein-engineered IL-12, exhibits tumor-selective activity in mice without peripheral toxicities and is well tolerated in non-human primates

Title
719 XTX301, a protein-engineered IL-12, exhibits tumor-selective activity in mice without peripheral toxicities and is well tolerated in non-human primates
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue Suppl 2, Pages A748-A748
Publisher
BMJ
Online
2021-11-09
DOI
10.1136/jitc-2021-sitc2021.719

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search